NSE: SPARC
SUN PHARMA ADV.RES.CO.LTD
Price history
-4.12% over 3M
Performance
52-week range
Position in day range
SPARC stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Sideways
50-DMA ₹217.32
RSI (14)
51
Neutral momentum
Volatility (ATR)
3.87%
Moderate
Close streak
2d down
Volume vs 20d avg
0.78x
From 52W high
-31.87%
Up from 52W low
+82.32%
Green days (20)
7/20
Monthly seasonality
Average monthly move for SPARC across the available price history.
Key statistics
Open
200.58
Day high
204.6
Day low
196.25
Prev close
196.91
Volume
7.01 L
Avg vol (20d)
8.94 L
52W high
289
52W low
108
SPARC quarterly results
All SPARC results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹39.92 cr
+314.1% YoY
Net profit
-₹20.78 cr
+59.9% YoY
Operating profit
-₹36.2 cr
+33.9% YoY
EPS
₹-0.64
+60.0% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹39.92 cr | -₹36.2 cr | -₹20.78 cr | -90.7% | -52.1% | ₹-0.64 | +59.9% | -101.2% |
| Q4 FY262026-03-31 | ₹1,853 cr | ₹1,771 cr | ₹1,761 cr | 95.6% | 95.0% | ₹54.27 | — | +2290.2% |
| Q3 FY262025-12-31 | ₹8.45 cr | -₹59.21 cr | -₹80.42 cr | -700.7% | -951.7% | ₹-2.48 | — | -6.0% |
| Q2 FY262025-09-30 | ₹7.86 cr | -₹68.28 cr | -₹75.85 cr | -868.7% | -965.0% | ₹-2.34 | — | -46.2% |
| Q1 FY262025-06-30 | ₹9.64 cr | -₹54.76 cr | -₹51.87 cr | -568.0% | -538.1% | ₹-1.60 | — | — |
| TTM (last 4 quarters) | ₹1,909 cr | ₹1,607 cr | ₹1,584 cr | 84.2% | 83.0% | ₹48.81 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹204.00 on Rising Newsflow
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹200.58, -2.69 (-1.34%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹205.87: What Is Driving SPARC Today, and the Levels That Matter
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹205.87 After M&A Update — Levels, Volumes and the Follow-Up to Track
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%) as the m&a story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Sun Pharma Adv.Res.Co.Ltd Sees 2.6x Volume Spike — Should Investors Read This as a Trend or a One-Day Move?
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹199.58, +2.60 (+1.30%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹199.33 — Should Investors Read This as a Trend or a One-Day Move?
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹196.98, -2.35 (-1.19%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Sun Pharma Adv.Res.Co.Ltd Share Price Drops 4.20% to ₹199.33: What Is Driving SPARC Today, and the Levels That Matter
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹199.33, -8.38 (-4.20%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Sun Pharma Adv.Res.Co.Ltd Share Price Trades Flat at ₹195.66 — Here Is What Is Driving SPARC Today
Sun Pharma Adv.Res.Co.Ltd (SPARC) is at ₹195.66, +0.68 (+0.35%) — price is holding almost unchanged despite the coverage. Live board, the newsflow around it, and the levels that decide what happens next.
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.